Enterprise League logo
Naveris, Inc. Logo

Naveris, Inc.

Waltham, United States (US) · Health and Medical

Do you work at Naveris, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#liquid biopsies for early detection

#drug discovery & validation

#patient & drug selection

Naveris, Inc. is a Health and Medical company based in Waltham, United States (US), with 100-150 employees. Naveris, Inc.'s profile is verified on Enterprise League.

Overview

Naveris, Inc is a Waltham, Massachusetts-based molecular diagnostics company focused on transforming cancer detection. We develop and commercialize highly sensitive blood tests, known as liquid biopsies, that identify viral cancers significantly earlier than traditional methods. Our flagship product, NavDx®, utilizes proprietary technology to detect tumor-tissue-modified DNA (TTMV) in blood, enabling real-time monitoring of HPV-related cancers and facilitating early detection of recurrence.

At Naveris, our mission is to deliver disruptive technology with the potential to transform cancer detection and improve patient outcomes. We are dedicated to providing clinicians with a powerful tool for proactive surveillance and personalized treatment strategies.

Naveris’ technology has demonstrated significant advantages in detecting cancer recurrence, with NavDx® establishing a lead-time of up to 3.9 months in clinical studies.

We are a growing team of scientists and experts committed to advancing the field of liquid biopsy and ultimately, saving lives.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@naveris.com

Waltham, United States (US), 21 Hickory Drive, Suite 600

+1

Company Type

Private Limited Company

Employees

100-150

Categories

Biopharma
Life Science
Biotechnology

Keywords

#liquid biopsies for early detection

#drug discovery & validation

#patient & drug selection

Awards

• 2026 OpenSee all

Services

Default Product Image
NavDx®
Biotechnology

NavDx® is a liquid biopsy test that uses proprietary technology to detect tumor-tissue-modified DNA (TTMV) in the blood, enabling ultrasensitive surveillance of HPV-related cancer. It is used to monitor head & neck cancer recurrence.

N/A

Companies teams usually look at after Naveris, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.